Medication info
Tenegliptin M Extended-release Tablet 20/1000 mg

Tenegliptin M Extended-release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Korea Pavis Pharmaceutical Co., Ltd.
Appearance
Pink oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201429 · Approved 2022.04.04 · Insurance code 621804470

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Ingredients

Manufacturer
Korea Pavis Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps improve blood sugar control in patients with type 2 diabetes by combining teneligliptin and metformin. When administered alongside diet and exercise therapy, it effectively manages blood sugar levels. It is used to enhance blood sugar control and alleviate diabetes symptoms.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Precautions

This medication is used for the treatment of diabetes and helps regulate blood sugar levels. During the course of treatment, there may be very rare occurrences of a serious side effect called lactic acidosis. Lactic acidosis is a condition resulting from excessive buildup of lactic acid in the body and can be life-threatening in severe cases, hence caution is required. Patients with moderate to severe renal impairment, heart failure, acute myocardial infarction, severe infections, or certain other diseases should not take this medication. Furthermore, the medication should be discontinued before undergoing tests that use radiologic contrast agents, and it should only be resumed after kidney function has been confirmed normal following the tests. It is also safer for women who are pregnant or may become pregnant to avoid taking this medication. The risk of hypoglycemia may increase if this medication is used in conjunction with other antidiabetic medications, so one must be well-informed about the symptoms of hypoglycemia and how to manage them. If any unusual symptoms such as persistent abdominal pain, vomiting, shortness of breath, skin rash, severe dizziness occur during treatment, consult a physician immediately. This medication is not recommended for patients with poor liver function, and patients should undergo regular kidney function and blood tests to monitor their health status. It is advisable to avoid alcohol, as excessive intake can increase the risk of lactic acidosis. After surgery or severe trauma, the medication should be temporarily discontinued as per the physician's instructions. Elderly patients often experience decreased kidney function, so renal function should be closely monitored when taking this medication. Vitamin B12 levels may decrease during treatment, so regular blood tests may be necessary. This medication is not recommended for children, as its safety and efficacy have not been established. When taking this medication, caution should be exercised when driving or engaging in hazardous work due to the risk of hypoglycemia or dizziness. In case of overdose, contact a healthcare facility immediately for appropriate treatment, which may involve dialysis in certain cases. Keep this medication out of reach of children, and do not transfer it to other containers.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, pemphigus vulgaris, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colon polyps, duodenal ulcer, gastroesophageal reflux disease, diarrhea, loss of appetite, amylase elevation, lipase elevation, AST (GOT) elevation, ALT (GPT) elevation, GGT elevation, ALP elevation, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, CK (CPK) elevation, serum potassium concentration elevation, fatigue, allergic rhinitis, serum uric acid elevation, peripheral edema, shingles, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremors, headache, weakness, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweat, diabetic retinopathy, vision loss, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, cerebral infarction, diabetic neuropathy, sensory abnormalities, arthralgia, nasopharyngitis, gastritis, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertension, cough, insomnia, urticaria, hepatic coma, sensory disturbance, sensory loss, tension-type headache, peripheral neuropathy, facial paralysis, sciatica, orthostatic dizziness, muscle weakness, back pain, lumbar spinal stenosis, tendinitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle cramps, foot deformity, hypertrophic osteoarthropathy, bursitis, spinal osteoarthritis, spinal disc herniation, spinal disc disorder, spinal ligament calcification, spinal foramen stenosis, postmenopausal osteoporosis, rotator cuff syndrome, gastritis, vomiting, chronic gastritis, abdominal pain, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anal rectal discomfort, secondary mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, dyspnea, exertional dyspnea, atelectasis, nasal bleeding, chest discomfort, fever, chills, generalized edema, injection site inflammation, chest pain, ureteral calculi, dysuria, renal cysts, nocturia, depression, anxiety disorder due to general medical conditions, ovarian cysts, vulvar pruritus, menopausal symptoms, bile duct obstruction, toxic hepatitis, chronic cholecystitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip injury, contusion, cataract, glaucoma, blurry vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, vertigo, iron deficiency anemia, food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air from entering, and keep it at a temperature between 1°C and 30°C at room temperature. Storing it this way preserves the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Pink oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.